The management of Leishmania donova ni (LD), responsible for fatal visceral leishmaniasis (VL), faces increasing challenges due to rising drug-unresponsiveness, leading to increasing treatment ...

including cancer, metabolic diseases, and neurodegeneration. For more information about the Farese and Walther Lab, please visit our website. Arlt H, Sui X, Folger B, Adams C, Chen X, Remme R, ...